17 jul: Parken: FCK forhandler med flere om N'Doye-salg
18 jul: OPTAKT Nordea Q2 18/7: Drift holdt nede af nedskrivninger
17-07-2012 23:37:00

GlaxoSmithKline and Amicus Expand Drug Collaboration

Relateret indhold

By Ben Fox Rubin

Amicus Therapeutics Inc. (FOLD) and GlaxoSmithKline PLC (GSK, GSK.LN) said they are expanding their collaboration to develop a treatment for Fabry disease, with Glaxo agreeing to buy a larger stake in the smaller pharmaceutical company.

The deal includes co-development of all current and future formulations of migalastat HCl for Fabry disease, which is a lipid storage disorder, as well as a commercialization arrangement for all future Fabry products. Amicus will have commercial rights in the U.S., while Glaxo will have rights for the rest of the world.

Glaxo also agreed to buy $18.6 million in Amicus's common stock at $6.30 a share, a 4.7% premium over Tuesday's close, raising its ownership in the company to 20%.

"Through our expanded agreement, GSK is increasing its investment in the Fabry development program and Amicus is transforming into a commercial-stage biopharmaceutical company within the U.S.," said Amicus Chief Executive John Crowley.

Amicus makes oral therapeutics known as pharmacological chaperones to treat a range of human genetic diseases.

Its shares closed Tuesday at $6.02, while Glaxo's closed at $45.44. Neither were active after hours.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 17, 2012 17:37 ET (21:37 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

KORR: Mærsk: Fragtrater tager stort hop mellem Asien og Europa

29-04-2016 15:27:20
(Korr: rettet procenttal der var forkerte hos Journal of Commerce, red.)I den seneste uge er priserne for at fragte en container fra Asien til Europa i gennemsn..

Mærsk: Fragtrater tager stort hop mellem Asien og Europa -citat

29-04-2016 14:40:33
I den seneste uge er priserne for at fragte en container fra Asien til Europa i gennemsnit steget med hele 62 pct. Det skriver branchemediet Journal of Commerce..

Aktier/åbning: Tretrinsraket skyder Vestas i top - Novo daler

29-04-2016 09:20:42
Morgenstundens regnskaber fredag faldt mest positivt ud for Vestas, der efter få minutters handel ligger i spidsen af eliteindekset C20 Cap.Også Danske Bank og ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas: Stærk ordreindgang blæser forventningerne omkuld
2
Aktier/middag: Vestas og Danske Bank belønnes, Novo straffes
3
Aktier/tendens: Novo, Vestas og Danske kan afgøre vejen
4
KORR: Vestas: Stærk ordreindgang blæser forventningerne omkuld
5
Aktier/åbning: Tretrinsraket skyder Vestas i top - Novo daler

Relaterede aktiekurser

GlaxoSmithKline PLC 1.459,00 -2,0% Fald i aktiekurs
GlaxoSmithKline PLC 42,87 -1,1% Fald i aktiekurs
Amicus Therapeutics Inc 7,42 -4,3% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
29. april 2016 17:53:47
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20160421.1 - EUROWEB4 - 2016-04-29 17:53:47 - 2016-04-29 17:53:47 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x